Učitavanje...
Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
BACKGROUND/AIMS: At our hemodialysis (HD) unit, we noted a drop in the treatment dose of erythropoietin-stimulating agents (ESAs) when the frequency of dose adjustment was reduced from weekly, where doses were withheld if hemoglobin was >130 g/l, to monthly, where doses were not withheld. The aim...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3290861/ https://ncbi.nlm.nih.gov/pubmed/22470378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000329889 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|